Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion

Anna Bauer, Markus Khalil, Monika Lüdemann, J. rgen Bauer, Anoosh Esmaeili, Roberta de-Rosa, Norbert F. Voelkel, Hakan Akintuerk, Dietmar Schranz

Research output: Contribution to journalArticleAcademicpeer-review


Background: Left atrial decompression is considered in patients with symptomatic heart failure with preserved ejection fraction (HFpEF). We aimed to evaluate the feasibility and efficacy of transcatheter generation of a restrictive atrial septum communication to manage HFpEF from infancy to adulthood with cardiomyopathy and congenital heart defect. Methods and results: From June 2009 to December 2016, 24 patients (50% with an age less than 16 years) with HFpEF were palliated; NYHA-/Ross class IV (n = 10); median systemic ventricular ejection fraction 64 (range 35–78) %. Cardiomyopathy was classified as a restrictive (n = 4) or hypertrophic (n = 2). (75% related to congenital heart defects) Three patients had a systemic right ventricle; in the majority of patients, HFpEF was associated to complex congenital heart defects (n = 18). Mean pulmonary arterial pressures (PAP systolic/diastolic) were 56/28 (± 24/13), left atrial pressures (LAP, v-, a-wave, mean) 26/25/20 (± 7/10/6). Trans-septal puncture was used in 22 patients; foramen ovale dilatation in 2 patients. Median balloon size was 12 (range 6–18) mm; procedure time including diagnostic measures 125 (83–221) min. No procedural death or complications were observed. Mean LA-pressures decreased significantly to 19/19/15 ± 6/8/5 mmHg (p = 0.05); median brain natriuretic peptide (BNP) decreased from 392 (range 93–4401) pg/ml median BNP to 314 (range 61–1544) pg/ml (p = 0.05). Three patients died; one patient received orthotopic heart and one patient a heart–lung transplantation. No patient required so far an assist device. Clinical improvement occurred in all patients, in some after additional surgical or interventional approach. Conclusions: Transcatheter LA decompression is an age-independent, effective palliation treating patients with HFpEF.
Original languageEnglish
Pages (from-to)845-857
JournalClinical Research in Cardiology
Issue number9
Publication statusPublished - 2018

Cite this